PAHC Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
396.7M
+3.4%
383.5M
+2.6%
373.9M
+2.8%
363.9M
-3.9%
378.7M
Cost of Revenue
262.3M
+1.7%
257.9M
+6.9%
241.3M
-1.2%
244.1M
-9.1%
268.7M
Gross Profit
134.4M
+6.9%
125.7M
-5.3%
132.7M
+10.7%
119.8M
+8.9%
110.0M
Operating Expenses
86.2M
+6.4%
81.0M
-1.6%
82.3M
+20.1%
68.5M
-10.2%
76.3M
R&D
0
0
0
0
0
SG&A
86.2M
+6.4%
81.0M
-1.6%
82.3M
+20.1%
68.5M
-10.2%
76.3M
Operating Income
48.2M
+7.8%
44.7M
-11.3%
50.3M
-1.8%
51.3M
+52.0%
33.7M
EBITDA
61.5M
+7.7%
57.1M
-9.7%
63.2M
-1.4%
64.1M
+38.9%
46.1M
Net Income
21.7M
-9.6%
24.0M
-12.5%
27.5M
+3.5%
26.5M
+54.0%
17.2M
EPS (Basic)
$0.54
-8.5%
$0.59
-13.2%
$0.68
+4.6%
$0.65
+54.8%
$0.42
EPS (Diluted)
$0.53
-10.2%
$0.59
-11.9%
$0.67
+3.1%
$0.65
+54.8%
$0.42
Shares (Diluted)
41.0M
-0.1%
41.0M
+0.2%
41.0M
+0.2%
40.9M
+0.4%
40.7M
Phibro Animal Health (PAHC) โ€” Financials